Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Brain Neoplasms × Sunitinib × Clear all

Phase

Status

Completed 5 Terminated 3 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 12 Neoplasm Metastasis 5 Kidney Neoplasms 5 Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hormone Refractory Prostate Cancer 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

Radiosurgery 11 Temozolomide 10 Radiotherapy 10 Magnetic Resonance Spectroscopy 7 Erlotinib Hydrochloride 6 Surgical Procedures, Operative 5 Pemetrexed 5 Gefitinib 5 Drug Therapy 5 Carboplatin 5 Bevacizumab 5 pyrotinib 4 icotinib 4 aumolertinib 4 Trastuzumab 3 Spermine Synthase 3 Radiation 3 Lomustine 3 Etoposide 3 Dexmedetomidine 3 Chlorotoxin 3 Carmustine 3 osimertinib 2 camrelizumab 2 apatinib 2 Tyrosine Kinase Inhibitors 2 Thiotepa 2 Surveys and Questionnaires 2 Sevoflurane 2 Propofol 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03025893 2021-04-19

STELLAR

Amsterdam UMC, location VUmc

Phase 2/3 Unknown

Brain Neoplasms, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡